Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 187,100 | 112,300 | 141,714 | 254,712 | 83,267 |
| Marketable Securities | 613,900 | 558,200 | 509,199 | 261,217 | 224,083 |
| Receivables | 157,100 | 126,600 | 57,406 | 31,127 | N/A |
| Inventories | 28,000 | 17,300 | 10,864 | 1,024 | N/A |
| Other current assets | 30,100 | 16,600 | 18,594 | 6,839 | 3,092 |
| TOTAL | $1,016,200 | $831,000 | $737,777 | $554,919 | $310,442 |
| Non-Current Assets | |||||
| PPE Net | 44,600 | 41,900 | 33,869 | 10,811 | 6,271 |
| Investments And Advances | 265,300 | 355,600 | 216,028 | 247,361 | 43,490 |
| Other Non-Current Assets | 408,600 | 77,500 | 5,477 | 4,500 | 4,883 |
| TOTAL | $718,500 | $475,000 | $255,374 | $262,672 | $54,644 |
| Total Assets | $1,734,700 | $1,306,000 | $993,151 | $817,591 | $365,086 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 168,700 | 141,300 | 86,377 | 53,520 | 26,182 |
| Other current liabilities | 17,800 | 15,200 | 1,856 | 906 | N/A |
| TOTAL | $186,500 | $565,300 | $88,233 | $54,426 | $30,414 |
| Non-Current Liabilities | |||||
| Long Term Debt | 317,900 | 0 | 388,496 | 369,618 | N/A |
| Deferred Revenues | N/A | N/A | N/A | N/A | 3,996 |
| Other Non-Current Liabilities | 104,100 | 103,800 | 35,657 | 3,135 | 1,575 |
| TOTAL | $422,000 | $103,800 | $424,153 | $391,027 | $19,795 |
| Total Liabilities | $608,500 | $669,100 | $512,386 | $445,453 | $50,209 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 93,944 | 92,292 | 90,821 | 89,274 | 87,114 |
| Common Shares | 100 | 100 | 91 | 89 | 87 |
| Retained earnings | -725,400 | -1,132,700 | -1,177,755 | -1,198,866 | -1,056,324 |
| Other shareholders' equity | 1,800 | 1,400 | -1,932 | -1,850 | -318 |
| TOTAL | $1,126,200 | $636,900 | $480,765 | $372,138 | $314,877 |
| Total Liabilities And Equity | $1,734,700 | $1,306,000 | $993,151 | $817,591 | $365,086 |